WeTrials
Recruiting

A Post-market Multi-center Prospective Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Breast Cancer Stages I-III.

What is this study?

This study is testing a special portable cooling cap designed to help women prevent hair loss while receiving chemotherapy for early-stage breast cancer. The goal is to see how well the device works while also checking its safety, comfort, and impact on your quality of life.

Who can participate?

You may be able to join if you are a woman aged 21 or older with stage 1, 2, or 3 breast cancer who is planning to receive specific chemotherapy treatments. You cannot participate if you already have significant hair thinning, specific immune system conditions that cause hair loss, or prior whole-brain radiation.

What will happen?

During your chemotherapy sessions, you will wear a portable cooling cap on your head to help protect your hair follicles from the medicine. The study team will check on your hair preservation, comfort, and overall satisfaction throughout your treatment journey.

Where and when?

This study is currently active and recruiting participants at locations in Tucson, Arizona, and Urbana, Illinois.

Key Points
  • 1Tests a portable cooling cap to prevent chemotherapy-induced hair loss.
  • 2Open to women 21 and older with stage 1 to 3 breast cancer.
  • 3Currently recruiting patients at sites in Arizona and Illinois.

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
AlopeciaChemotherapy-induced AlopeciaHair LossBreast Cancer

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.